Lars Kristian Munck

Lars Kristian Munck is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Internal Medicine with a focus on Gastroenterology and Hepatology. Based at Lykkebækvej 1, 4600 Køge, Denmark, he maintains dual academic-clinical affiliations through the University of Copenhagen and Region Sjælland healthcare system.

Dr. Munck's research program centers on gastrointestinal disorders, particularly bile acid metabolism abnormalities and inflammatory bowel conditions. His work spans diagnostic methodology development, clinical trial design, and epidemiological analysis of long-term outcomes. Key research themes include bile acid diarrhea pathophysiology and treatment, microscopic colitis progression, and the relationship between gastrointestinal disorders and cancer risk. His methodological expertise includes designing prospective cohort studies, randomized controlled trials, and diagnostic test comparisons.

Analysis of Dr. Munck's publication record reveals a consistent focus on clinically relevant gastrointestinal research with immediate patient care applications. His work demonstrates particular strength in designing and executing large-scale clinical studies, including the European Microscopic Colitis Group cohort and Danish nationwide registry studies. Recent publications show increasing attention to diagnostic accuracy and treatment personalization in complex gastrointestinal conditions.

Dr. Munck maintains extensive European collaborations, particularly through the European Microscopic Colitis Group [EMCG]. His research has gained significant traction in the medical community, with multiple publications referenced in clinical guidelines and disseminated through academic platforms, social media channels, and news outlets. His work on colesevelam for bile acid diarrhea treatment published in The Lancet Gastroenterology and Hepatology has received substantial citation attention with 41 Scopus citations.